Profiel
Erik Mascher is currently the Chief Technology Officer at Karessa Pharma Holding AB since 2015.
Prior to this, he worked as a Director at MAKK Consulting AB, Vice President-Process Development & Production at Resistentia Pharmaceuticals AB, and Section Manager & Senior Scientist at General Electric Healthcare España SA. Dr. Mascher holds a doctorate degree from the University of Uppsala.
Actieve functies van Erik Mascher
| Bedrijven | Functie | Begin |
|---|---|---|
| KARESSA PHARMA HOLDING AB (PUBL) | Hoofd Techniek/Wetenschap/O&O | 01-01-2015 |
Eerdere bekende functies van Erik Mascher
| Bedrijven | Functie | Einde |
|---|---|---|
MAKK Consulting AB | Directeur/Bestuurslid | - |
General Electric Healthcare España SA
General Electric Healthcare España SA Wholesale DistributorsDistribution Services Wholesales photographic material | Corporate Officer/Principal | - |
Resistentia Pharmaceuticals AB
Resistentia Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops immunotherapy products | Corporate Officer/Principal | - |
Opleiding van Erik Mascher
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Resistentia Pharmaceuticals AB
Resistentia Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops immunotherapy products | Health Technology |
University of Uppsala
University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
General Electric Healthcare España SA
General Electric Healthcare España SA Wholesale DistributorsDistribution Services Wholesales photographic material | Distribution Services |
Karessa Pharma Holding AB
Karessa Pharma Holding AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products to treat erectile dysfunction | Health Technology |
MAKK Consulting AB |
















